House Leaders Seek GAO Review Of Possible "Anticipatory Price Gouging" By Drug Firms
This article was originally published in The Pink Sheet Daily
Executive Summary
Prompted by recent studies indicating drug prices may be rising more quickly than usual, Reps. Waxman and Rangel seek expedited review of pricing trends. Sen. Nelson requests similar review by OIG, pledges Medicare rebate amendment.
You may also be interested in...
Rx Price Hikes In Advance Of Health Bill Will Get OIG Probe
Sen. Bill Nelson continues campaign to extract more concessions from pharmaceutical industry as part of health care reform legislation.
Rx Price Hikes In Advance Of Health Bill Will Get OIG Probe
Sen. Bill Nelson continues campaign to extract more concessions from pharmaceutical industry as part of health care reform legislation.
Part D Coverage Gap Relief Added To Senate Health Reform Bill; Is It Enough?
The merged Senate health reform bill includes a new provision that would narrow the Medicare Part D coverage gap by $500 in 2010